Tumor-resident probiotic Clostridium butyricum improves aPD-1 efficacy in colorectal cancer models by inhibiting IL-6-mediated immunosuppression

Journal:
Cancer Cell
Published:
DOI:
10.1016/j.ccell.2025.07.012
Affiliations:
2
Authors:
14
Go to article
Institutions Authors Share
State Key Laboratory of Digestive Disease, CUHK, China
13.000000
13.000000
 0.93
The First Affiliated Hospital, SYSU, China
1.000000
 0.07
Interested in Clinical Sciences?